HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2016, Vol 4, Issue 5

Abstract

Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. The A1C test is a blood test that provides information about a person’s average levels of blood glucose, also called blood sugar, over the past 3 months. The Aim is to study roll of HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. The Study consists of 120 type 2 DM patients of 40-70 year age group along with age and sex matched healthy control. Fasting Blood samples were collected from all participants for measurement of Lipid profile, Blood sugar (FBS) and HbA1c. In case group, the mean concentration of Fasting blood glucose(mg/dl), S.Cholestrol (mg/dl), S.Triglyceride (mg/dl), S.HDL(mg/dl) and HbA1c(%) is 138.5±5.2, 265±10.5, 210.9±5.2, 38.6±6.3 and 10.6±1.0. Respectively while in control group it is 85.6±6, 156.9±8.5, 119.5±7.3, 44.5±3.2 and 5.2±0.5 respectively. The HbA1C might be used as a reliable biomarker in the screening of dyslipidemia in diabetes type-2 patients because it showed positive correlation with TC, TG, VLDL, and LDL-C but negative correlation with HDL-C. Keywords: HbA1c, dyslipidemia Type 2 Diabetes mellitus

Authors and Affiliations

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani

Keywords

Related Articles

Combined Pulmonary Fibrosis and Emphysema (CPFE): A distinct Clinico-Radiological entity

Combined pulmonary fibrosis and emphysema (CPFE) is a common yet under diagnosed entity with imaging findings of both pulmonary emphysema and fibrosis.Many have challenged the definition of CPFE and there still exists a...

Endoscopic Adenoidectomy with Microdebrider

This present study was conducted to describe endoscopic power assisted adenoidectomy and review the experience regarding safety and effectiveness. 38 patients, who under vent power assisted adenoidectomy aged between 6to...

Study of Malaria Complicating Pregnancy: Our Experience

Malaria in pregnancy entails a grave risk to the mother and fetus. Currently 25 million pregnant women are at risk for malaria. According to the report of World Health Organization (WHO), malaria accounts for over 10,000...

A prospective study of adverse drug reactions monitoring in a tertiary care hospital, Rewa (MP)

Abstract: The aim of study is to determine the pattern of suspected ADRs reported in ICU and ward admitted patients in a tertiary care hospital. Study was conducted in the department of Pharmacology and department of Med...

Comparison of Clonidine and Dexmedetomidine for Attenuation of Hemodynamic Responses of Intubation and Pneumoperitoneum During Laparoscopic Cholecystectomy: A Randomized Double Blind Placebo Controlled Trial

Hemodynamic derangements, associated with intubation and pneumoperitoneum during laparoscopic surgery can be attenuated by use of α2 agonist drugs like clonidine and dexmedetomidine. To compare the attenuating effects of...

Download PDF file
  • EP ID EP371045
  • DOI -
  • Views 44
  • Downloads 0

How To Cite

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani (2016). HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. Scholars Journal of Applied Medical Sciences, 4(5), 1600-1602. https://europub.co.uk/articles/-A-371045